Scholarly article on topic 'OR9-001 - Exome sequencing in monogenic Behçet-like disease'

OR9-001 - Exome sequencing in monogenic Behçet-like disease Academic research paper on "Veterinary science"

0
0
Share paper
Academic journal
Pediatr Rheumatol
OECD Field of science
Keywords
{""}

Academic research paper on topic "OR9-001 - Exome sequencing in monogenic Behçet-like disease"

Zhou et al. Pediatric Rheumatology 2013, 11(Suppl 1):A184 http://www.ped-rheum.com/content/11/S1/A184

t % PEDIATRIC

RHEUMATOLOGY

MEETING ABSTRACT

Open Access

OR9-001 - Exome sequencing in monogenic Behget-like disease

Q Zhou1*, R Laxer2, M Pelletier3, M Ramaswamy3, H-Y Wang4, D Chin1, A Gül5, C Sibley6, M Barat-Houari7, R Siegel3, DL Kastner1, I Aksentijevich1

From 7th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID) Lausanne, Switerland. 22-26 May 2013

Introduction

A Caucasian family with an affected mother and 2 affected daughters presented with early onset Behget-like disease, manifesting with arthralgia/arthritis, mouth and genital ulcers, and uveitis. They are negative for HLA*B51. Their symptoms are significantly ameliorated with TNF-inhibitors.

Objectives

To identify the causative mutation(s) in this family we sequenced the exomes of the 3 affected patients.

Methods

Exome data were filtered for novel variants not present in dbSNP, the 1000 Genomes Pilot Project, NHLBI Exome Sequencing Project (ESP5400), and 124 exomes from in-house data.

Results

We identified 21 putative candidate variants that are both novel and consistent with dominant inheritance. Sanger sequencing validated all 21 variants. Three variants identified in TNFRSF9, MGEA5, and TNFAIP3 genes were confirmed to have arisen de novo in the affected mother based on the genotyping of the healthy maternal grandmother, the maternal unaffected brother, and the unaffected paternal aunt. The candidate variant in MGEA5 was predicted as benign by PolyPhen-2. The 2 candidate variants that remained for consideration are p.C78W (TNFRSF9; CD137; 4-1BB) and p.L227X (TNFAIP3;A20). Haplotype analysis showed that p.C78W occurred de novo on the haplotype inherited from the grandmother. The p.L227X mutation-associated haplotype was found on the

inflammatory Disease Section, NationalHuman Genome Research Institute (NHGRI/NIH), Bethesda, USA

Fulllist of author information is available at the end of the article

Bio Med Central

grandfather's haplotype; his sample is not available for analysis. Because we reached the limit for further analysis of candidate variants in the family, we studied 6 Turkish familial Behget cases and 56 sporadic Caucasian cases. All of these individuals were negative for mutations in either candidate gene. Both 4-1BB and A20 are strong candidates and potentially in the same signaling pathway. 4-1BB is a TNF-family receptor that costimulates T cell responses and promotes survival of lymphocytes and dendritic cells; A20 is a negative regulator of NF-kB activation by TNF and TLR family receptors. Mutant 4-1BB expressed in Jurkat cells was associated with reduced expression on the plasma membrane, and activated T cells from all 3 patients had a marked decrease in surface expression, especially in CD8+ T cells. Despite reduced surface expression, the C78W TNFRSF9 mutation could have a gain-of-function phenotype like TNFR1 mutations in TRAPS, leading to intracellular retention of mutant protein and spontaneous signaling, which in this case could amplify immune responses by T cells and other cell types expressing 4-1BB. Patient peripheral blood cells also had lower total A20 protein levels relative to controls and, consistent with A20 lack of function, increased I-kB degradation after cellular activation.

Conclusion

Behget-like disease in this family is associated with mutations in 2 genes that affect immune cell survival and production of inflammatory cytokines. Additional functional studies will determine whether 1 or both mutations may contribute to this dominantly-inherited phenotype.

Competing interests

None declared.

© 2013 Zhou et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Zhou et al. Pediatric Rheumatology 2013, 11(Suppl 1):A184 http://www.ped-rheum.com/content/11/S1/A184

Page 2 of 2

Authors' details

inflammatory Disease Section, NationalHuman Genome Research Institute (NHGRI/NIH), Bethesda, USA. 2Hospitalfor Sick Children, Toronto, Canada. 3Immunoregulation Section, National Institute of Arthritis and Musculoskeletaland Skin (NIAMS/NIH), USA. 4Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases (NIAID/NIH), Bethesda, USA,. 5IstanbulFaculty of Medicine, IstanbulUniversity, Istanbul, Turkey. 6Office of ClinicalDirector, NationalInstitute of Arthritis and Musculoskeletal and Skin (NIAMS/NIH), Bethesda, USA. 'Département de Génétique, LBM -CHU de Montpellier, Montpellier, France.

Published: 8 November 2013

doi:10.1186/1546-0096-11-S1-A184

Cite this article as: Zhou et al.: OR9-001 - Exome sequencing in monogenic Behçet-like disease. Pediatric Rheumatology 2013 11 (Suppl 1): A184.

Submit your next manuscript to BioMed Central and take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at fpntral

www.biomedcentral.com/submit v-enudi